These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 1403062)

  • 21. An IRB member's perspective on access to innovative therapy.
    Moore DL
    Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
    [No Abstract]   [Full Text] [Related]  

  • 22. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials and physicians as double agents.
    Levine RJ
    Yale J Biol Med; 1992; 65(2):65-74. PubMed ID: 1519378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members.
    Van Luijn HE; Musschenga AW; Keus RB; Robinson WM; Aaronson NK
    Ann Oncol; 2002 Aug; 13(8):1307-13. PubMed ID: 12181256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomedical and behavioral research in nursing homes: guidelines for ethical investigations.
    Sachs GA; Rhymes J; Cassel CK
    J Am Geriatr Soc; 1993 Jul; 41(7):771-7. PubMed ID: 8315190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 1 oncology trials and informed consent.
    Miller FG; Joffe S
    J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol review within the context of a research program.
    Miller FG; Rosenstein DL
    IRB; 1998; 20(4):7-10. PubMed ID: 11657088
    [No Abstract]   [Full Text] [Related]  

  • 28. Informed consent in the Childrens Cancer Group: results of preliminary research.
    Kodish ED; Pentz RD; Noll RB; Ruccione K; Buckley J; Lange BJ
    Cancer; 1998 Jun; 82(12):2467-81. PubMed ID: 9635541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine.
    Matot I; Pizov R; Sprung CL
    Crit Care Med; 1998 Sep; 26(9):1596-602. PubMed ID: 9751600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local Research Ethics Committees can audit ethical standards in research.
    Berry J
    J Med Ethics; 1997 Dec; 23(6):379-81. PubMed ID: 9451608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceptions of cancer patients and their physicians involved in phase I trials.
    Daugherty C; Ratain MJ; Grochowski E; Stocking C; Kodish E; Mick R; Siegler M
    J Clin Oncol; 1995 May; 13(5):1062-72. PubMed ID: 7738612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Institutional review board approval and publication of human research results.
    Amdur RJ; Biddle C
    JAMA; 1997 Mar; 277(11):909-14. PubMed ID: 9062330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.
    JAMA; 1997 Mar; 277(11):925-6. PubMed ID: 9062334
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group.
    Estlin EJ; Cotterill S; Pratt CB; Pearson AD; Bernstein M
    J Clin Oncol; 2000 May; 18(9):1900-5. PubMed ID: 10784630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposed guidelines for the participation of persons with dementia as research subjects.
    Keyserlingk EW; Glass K; Kogan S; Gauthier S
    Perspect Biol Med; 1995; 38(2):319-61. PubMed ID: 11644666
    [No Abstract]   [Full Text] [Related]  

  • 36. Communication about the risks and benefits of phase I pediatric oncology trials.
    Hazen RA; Zyzanski S; Baker JN; Drotar D; Kodish E
    Contemp Clin Trials; 2015 Mar; 41():139-45. PubMed ID: 25638751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approving high risk, rejecting low risk: the case of two cases.
    Shannon TA; Ockene IS; Levine RJ
    IRB; 1985; 7(1):6-8. PubMed ID: 11649618
    [No Abstract]   [Full Text] [Related]  

  • 38. Ethical and human-rights issues in research on mental disorders that may affect decision-making capacity.
    Capron AM
    N Engl J Med; 1999 May; 340(18):1430-4. PubMed ID: 10228198
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase I cancer trials. A collusion of misunderstanding.
    Miller M
    Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892
    [No Abstract]   [Full Text] [Related]  

  • 40. Is informed consent always necessary for randomized, controlled trials?
    Truog RD; Robinson W; Randolph A; Morris A
    N Engl J Med; 1999 Mar; 340(10):804-7. PubMed ID: 10072420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.